Search for content, post, videos

Immunovia Inc to begin patient testing in the US

Immunovia lab
Immunovia, Inc has received final approval to begin patient testing for the IMMray PanCan-d test. The IMMray PanCan-d test is the first blood test on the market dedicated to the early detection of pancreatic cancer. “We are extremely pleased to have achieved this important milestone and to b
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.